ZT
Zoetis
ZTS·NYSEParsippany NJFounded 195213,000 employees
Large CappharmaPublicOncology
Platform: Animal Health
Market Cap
$85B
All Drugs
12
Clinical Trials
23
Failed / Terminated
4
FDA Approved
1
Stock Price & Catalysts (ZTS)
Loading ZTS stock data...
Drug Pipeline (12 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Talalemzoparlimab | ZTS-5682 | Phase 2/3 | 1 | IL-23 | Bladder CaGastric Ca | ||
| ZTS-7367 | ZTS-7367 | Preclinical | 1 | PD-1 | Narcolepsy | ||
| Elralucimab | ZTS-3997 | Phase 1/2 | 2 | SOS1 | ThymomaAS | ||
| Kemamavacamten | ZTS-5234 | Phase 3 | 4 | B7-H3 | NSCLC | ||
| ZTS-820 | ZTS-820 | NDA/BLA | 1 | SOS1 | DMDCrohn's | ||
| Daranaritide | ZTS-2384 | Phase 2/3 | 2 | SMN2 | Wet AMD | ||
| Riluzumab | ZTS-4788 | Approved | 3 | SHP2 | Hemophilia APsA | ||
| ZTS-4049 | ZTS-4049 | Phase 2 | 1 | Nectin-4 | HNSCCADHD | ||
| ZTS-7862 | ZTS-7862 | Phase 1/2 | 2 | Menin | MDS | ||
| ZTS-7156 | ZTS-7156 | Preclinical | 1 | TIGIT | HNSCCCrohn's | ||
| Fixazanubrutinib | ZTS-9957 | Preclinical | 1 | EZH2 | AsthmaEwing Sarcoma | ||
| ZTS-9629 | ZTS-9629 | Phase 3 | 4 | CFTR | NMOSDAS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (20)